VCAM1 and metabolic dysfunction-associated steatotic liver disease: Hence, the present study shows a critical role of LSEC VCAM1 in HSC activation and is consistent with previous human studies that indicate that serum levels of soluble VCAM1 can predict liver fibrosis severity in NAFLD patients (24).